Page 104 - Small Animal Internal Medicine, 6th Edition

76 PART I Cardiovascular System Disorders

Freeman LM, Rush JE. Nutritional management of heart disease. Oyama MA, et al. Use of the loop diuretic torsemide in three dogs
with advanced heart failure. J Vet Cardiol. 2011;13:287–292.
In: Ettinger SJ, Feldman EC, Cote E, eds. Textbook of veterinary Oyama MA, et al. Perceptions and priorities of owners of dogs with
VetBooks.ir Goutal CM, et al. Evaluation of acute congestive heart failure in heart disease regarding quality versus quantity of life for their
internal medicine. 8th ed. St. Louis: Elsevier; 2017:764–771.
dogs and cats: 145 cases (2007-2008). J Vet Emerg Crit Care.
pets. J Am Vet Med Assoc. 2008;233:104–108.
2010;20:330–337. Peddle GD, et al. Effect of torsemide and furosemide on clinical,
Haggstrom J, et al. Short-term hemodynamic and neuroendocrine laboratory, radiographic and quality of life variables in dogs with
effects of pimobendan and benazapril in dogs with myxomatous heart failure secondary to mitral valve disease. J Vet Cardiol.
mitral valve disease and congestive heart failure. J Vet Intern Med. 2012;14:253–259.
2013;27:1452–1462. Porciello F, et al. Sleeping and resting respiratory rates in dogs and
Haggstrom J, et al. Longitudinal analysis of quality of life, clinical, cats with medically-controlled left-sided congestive heart failure.
radiographic, echocardiographic, and laboratory variables in Vet J. 2016;207:164–168.
dogs with myxomatous mitral valve disease receiving pimoben- Rush JE, et al. Clinical, echocardiographic and neurohormonal
dan or benazepril: the QUEST study. J Vet Intern Med. 2013;27: effects of a sodium-restricted diet in dogs with heart failure. J Vet
1441–1451. Intern Med. 2000;14:512–520.
Haggstrom J, et al. Effect of pimobendan or benazepril HCl on Schober KE, et al. Effects of treatment on respiratory rate, serum
survival times in dogs with congestive heart failure caused by natriuretic peptide concentration, and Doppler echocardio-
naturally occurring myxomatous mitral valve disease: the graphic indices of left ventricular filling pressure in dogs with
QUEST study. J Vet Intern Med. 2008;22:1124–1135. congestive heart failure secondary to degenerative mitral valve
Helms SR, et al. Compounded pimobendan for canine chronic disease and dilated cardiomyopathy. J Am Vet Med Assoc.
degenerative mitral valve disease and pulmonary hypertension. 2011;239:468–479.
Int J Pharm Compd. 2012;16:34–41. Schuller S, et al. Lack of efficacy of low-dose spironolactone as
Hopper K, et al. Indications, management, and outcome of long- adjunct treatment to conventional congestive heart failure treat-
term positive-pressure ventilation in dogs and cats: 148 cases ment in dogs. J Vet Pharmacol Ther. 2011;34:322–331.
(1990-2001). J Am Vet Med Assoc. 2007;230:64–75. Slupe JL, Freeman LM, Rush JE. Association of body weight and
Kvart C, et al. Efficacy of enalapril for prevention of conges- body condition with survival in dogs with heart failure. J Vet
tive heart failure in dogs with myxomatous valve disease and Intern Med. 2008;22:561–565.
asymptomatic mitral regurgitation. J Vet Intern Med. 2002;16: Smith PJ, et al. Efficacy and safety of pimobendan in canine heart
80–88. failure caused by myxomatous mitral valve disease. J Small Anim
Lake-Bakaar GA, et al. Effect of pimobendan on the incidence of Pract. 2005;46:121–130.
arrhythmias in small breed dogs with myxomatous mitral valve Summerfield NJ, et al. Efficacy of pimobendan in the prevention of
degeneration. J Vet Cardiol. 2015;17:120–128. congestive heart failure or sudden death in Doberman Pinschers
Lefebvre HP, et al. Safety of spironolactone in dogs with chronic with preclinical dilated cardiomyopathy (the PROTECT Study).
heart failure because of degenerative valvular disease: a J Vet Intern Med. 2012;26:1337–1349.
population-based, longitudinal study. J Vet Intern Med. 2013;27: Suzuki S, et al. The effect of furosemide on left atrial pressure in
1083–1091. dogs with mitral valve regurgitation. J Vet Intern Med. 2011;25:
Lefebvre HP, et al. Angiotensin-converting enzyme inhibitors in 244–250.
veterinary medicine. Curr Pharm Des. 2007;13:1347–1361. Thomason JD, et al. The influence of enalapril and spironolactone
Lombarde CW, Jöns O, Bussadori CM. Clinical efficacy of pimo- on electrolyte concentrations in Doberman pinschers with
bendan versus benazepril for the treatment of acquired atrioven- dilated cardiomyopathy. Vet J. 2014;202:573–577.
tricular valvular disease in dogs. J Am Anim Hosp Assoc. Thomason JD, et al. Gingival hyperplasia associated with the
2006;42:249–261. administration of amlodipine to dogs with degenerative valvular
O’Grady MR, et al. Efficacy of pimobendan on case fatality rate in disease (2004-2008). J Vet Intern Med. 2009;23:39–42.
Doberman Pinschers with congestive heart failure caused by Vollmar AC, Fox PR. Long-term outcome of Irish Wolfhound dogs
dilated cardiomyopathy. J Vet Intern Med. 2008;22:897–904. with preclinical cardiomyopathy, atrial fibrillation, or both
O’Grady MR, et al. Efficacy of benazepril hydrochloride to delay treated with pimobendan, benazepril hydrochloride, or methyl-
the progression of occult dilated cardiomyopathy in Doberman digoxin monotherapy. J Vet Intern Med. 2016;30:553–559.
Pinschers. J Vet Intern Med. 2009;23:977–983. Ward DM, et al. Treatment of severe chronic digoxin toxicosis in a
Ohad DG, et al. Sleeping and resting respiratory rates in dogs with dog with cardiac disease, using ovine digoxin-specific immuno-
subclinical heart disease. J Am Vet Med Assoc. 2013;243: globulin G Fab fragments. J Am Vet Med Assoc. 1999;215:
839–843. 1808–1812.